Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Collaboration milestone payable — Current by Year
Collaboration milestone payable — Current ($M) ($M)
Vertex Pharmaceuticals Collaboration milestone payable — Current: $51.5M in FY2025, up 58.5% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Accrued Expenses / Collaborative Arrangements).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Collaboration milestone payable — Current ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 51.5 | +58.5% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 32.5 | -85.4% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 223 | – | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 0 | – | Form 10-K (filed 2024-02-15) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Collaboration milestone payable — Current ($M), annual FY2022–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/milestone-payable-cur
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.